Skip to main content

Amanda Van Swearingen

Research Program Leader, Sr
Medicine
232 Baker House, Trent Drive, Box #3381, Durham, NC 27710
20 Sydenham Road, Durham, NC 27713

Overview


Education and Training

Postdoctoral Research Associate, UNC-Chapel Hill, 01/2013-02/2017

PhD, Molecular Cancer Biology, Duke University, 2012

BS, Biology, Wake Forest University, 2007

Current Appointments & Affiliations


Research Program Leader, Sr Medicine, Clinical Science Departments

Recent Publications


Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology Collaborative.

Journal Article Neuro Oncol · October 1, 2025 Intracranial metastases (ICM), specifically parenchymal brain metastases, remain a major clinical challenge in solid tumor oncology, despite recent advances in cancer therapies which have led to improvements in survival for these patients. Improving outcom ... Full text Link to item Cite

A comprehensive, multi-center, immunogenomic analysis of melanoma brain metastases.

Journal Article Acta Neuropathol Commun · June 2, 2025 BACKGROUND: Melanoma brain metastases (MBM) have a unique molecular profile compared to extracranial metastases (ECM). Description of the biological features and clinical outcomes of MBM will facilitate the design of rational therapies. METHODS: We examine ... Full text Link to item Cite
View All Publications

Recent Grants


CNS PATTERN: CNS Progression After Targeted Therapy and Effect of Radiation in NSCLC

FellowshipData Manager · Awarded by Lung Cancer Initiative of North Carolina · 2025 - 2026

Ancestry-related RNA splicing and immune expression in metastatic breast cancer

ResearchResearch Associate · Awarded by Susan G. Komen Breast Cancer Foundation · 2022 - 2026

Breast Cancer Brain Metastases: Integrating Immunogenomic and Phenotypic Vulnerabilities to Improve Outcomes

ResearchProject Planner · Awarded by Department of Defense · 2025 - 2026

View All Grants